• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

4.480 +0.080 (+1.82%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,399,021
Open 4.240
Bid (Size) 4.300 (500)
Ask (Size) 4.750 (100)
Prev. Close 4.400
Today's Range 4.210 - 4.570
52wk Range 2.370 - 6.180
Shares Outstanding 136,360,208
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗
February 27, 2026
Cytek (CTKB) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗
February 26, 2026
Via Chartmill

Performance

YTD
-8.9%
-8.9%
1 Month
-10.6%
-10.6%
3 Month
-15.9%
-15.9%
6 Month
+11.4%
+11.4%
1 Year
-0.2%
-0.2%

More News

Read More
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
November 14, 2025
Via Benzinga
News headline image
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
November 12, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
August 06, 2025
Via Benzinga
News headline image
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock ↗
May 28, 2025
Via Benzinga
News headline image
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
November 06, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗
November 05, 2025
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
October 29, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
October 15, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
September 10, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For May 8, 2025 ↗
May 08, 2025
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
February 27, 2025
Via Benzinga
News headline image
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
May 29, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
May 28, 2025
Via Benzinga
News headline image
Cytek Biosciences Reports First Quarter 2025 Financial Results
May 08, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
April 29, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
March 18, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November ↗
December 30, 2024
Via Benzinga
News headline image
Crude Oil Gains 1%; Chicago PMI Falls In December ↗
December 30, 2024
Via Benzinga
News headline image
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday ↗
December 30, 2024
Via Benzinga
News headline image
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
December 30, 2024
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
November 19, 2024
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 19, 2024
Via Benzinga

Frequently Asked Questions

Is Cytek Biosciences, Inc. - Common Stock publicly traded?
Yes, Cytek Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Cytek Biosciences, Inc. - Common Stock trade on?
Cytek Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytek Biosciences, Inc. - Common Stock?
The ticker symbol for Cytek Biosciences, Inc. - Common Stock is CTKB on the Nasdaq Stock Market
What is the current price of Cytek Biosciences, Inc. - Common Stock?
The current price of Cytek Biosciences, Inc. - Common Stock is 4.480
When was Cytek Biosciences, Inc. - Common Stock last traded?
The last trade of Cytek Biosciences, Inc. - Common Stock was at 02/27/26 04:00 PM ET
What is the market capitalization of Cytek Biosciences, Inc. - Common Stock?
The market capitalization of Cytek Biosciences, Inc. - Common Stock is 610.89M
How many shares of Cytek Biosciences, Inc. - Common Stock are outstanding?
Cytek Biosciences, Inc. - Common Stock has 611M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap